Liu Y - Search Results

1

Targeted Covalent Inhibition of Telomerase.

Betori RC, Liu Y, Mishra RK, Cohen SB, Kron SJ, Scheidt KA. Betori RC, et al. Among authors: liu y. ACS Chem Biol. 2020 Mar 20;15(3):706-717. doi: 10.1021/acschembio.9b00945. Epub 2020 Feb 24. ACS Chem Biol. 2020. PMID: 32017522 Free PMC article.

2

O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.

Efimova EV, Appelbe OK, Ricco N, Lee SS, Liu Y, Wolfgeher DJ, Collins TN, Flor AC, Ramamurthy A, Warrington S, Bindokas VP, Kron SJ. Efimova EV, et al. Among authors: liu y. Mol Cancer Res. 2019 Jun;17(6):1338-1350. doi: 10.1158/1541-7786.MCR-18-1025. Epub 2019 Mar 18. Mol Cancer Res. 2019. PMID: 30885991 Free PMC article.

3

Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence.

Liu Y, Efimova EV, Ramamurthy A, Kron SJ. Liu Y, et al. J Cell Sci. 2019 Jul 1;132(13):jcs229385. doi: 10.1242/jcs.229385. J Cell Sci. 2019. PMID: 31189537 Free PMC article.

4

Small-molecule drug repurposing to target DNA damage repair and response pathways.

Brinkman JA, Liu Y, Kron SJ. Brinkman JA, et al. Among authors: liu y. Semin Cancer Biol. 2021 Jan;68:230-241. doi: 10.1016/j.semcancer.2020.02.013. Epub 2020 Feb 27. Semin Cancer Biol. 2021. PMID: 32113999 Free PMC article. Review.

5

Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization.

Liu Y, Betori RC, Pagacz J, Frost GB, Efimova EV, Wu D, Wolfgeher DJ, Bryan TM, Cohen SB, Scheidt KA, Kron SJ. Liu Y, et al. Cell Chem Biol. 2022 Oct 20;29(10):1517-1531.e7. doi: 10.1016/j.chembiol.2022.09.002. Epub 2022 Oct 6. Cell Chem Biol. 2022. PMID: 36206753 Free PMC article.

6

Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells.

Liu Y, Pagacz J, Wolfgeher DJ, Bromerg KD, Gorman JV, Kron SJ. Liu Y, et al. J Immunother Cancer. 2023 Feb;11(2):e005862. doi: 10.1136/jitc-2022-005862. J Immunother Cancer. 2023. PMID: 36792123 Free PMC article.

7

Protocol for examining the capability of senescent tumor cells to stimulate murine bone-marrow-derived dendritic cells by flow cytometry.

Liu Y, Kron SJ. Liu Y, et al. STAR Protoc. 2023 Dec 15;4(4):102677. doi: 10.1016/j.xpro.2023.102677. Epub 2023 Oct 31. STAR Protoc. 2023. PMID: 37897729 Free PMC article.

8

Clinical features and mutational spectrum of Chinese patients with primary hyperoxaluria type 2.

Liu Y, Zhao Z, Ge Y, He L, Qi S, Wang W. Liu Y, et al. Urolithiasis. 2024 May 10;52(1):74. doi: 10.1007/s00240-024-01579-y. Urolithiasis. 2024. PMID: 38727838

9

Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.

Ren S, Xiong A, Yu J, Wang X, Han B, Pan Y, Zhao J, Cheng Y, Hu S, Liu T, Li Y, Cheng Y, Feng J, Yi S, Gu S, Gao S, Luo Y, Liu Y, Liu C, Duan H, Wang S, Yang X, Fan J, Zhou C. Ren S, et al. Among authors: liu y. Cancer Immunol Immunother. 2024 May 10;73(7):124. doi: 10.1007/s00262-024-03715-4. Cancer Immunol Immunother. 2024. PMID: 38727837 Clinical Trial.

10

Percutaneous endoscopic transforaminal discectomy and unilateral biportal endoscopic discectomy for lumbar disc herniation: a comparative analysis of learning curves.

Li Z, Yang H, Zhang Y, Han C, Liu Y, Guan L, Yang J, Hai Y, Pan A. Li Z, et al. Among authors: liu y. Eur Spine J. 2024 May 10. doi: 10.1007/s00586-024-08293-8. Online ahead of print. Eur Spine J. 2024. PMID: 38727735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190,921 results

Search Page